Delta Investment Management, LLC
Source: SEC Form 13F · as of Mar 2026Delta Investment Management, LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $14.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$14.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 13,558 | $3.3M |
| RGENREPLIGEN CORP | 21,164 | $2.5M |
| LLYELI LILLY & Co | 1,483 | $1.4M |
| PMPhilip Morris International Inc | 6,827 | $1.1M |
| CAHCardinal Health Inc. | 4,834 | $1.0M |
| ABBVAbbVie Inc. | 4,101 | $892K |
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | 307,371 | $870K |
| MRKMerck & Co., Inc. | 5,643 | $679K |
| MCKMcKesson Corporation | 726 | $628K |
| ABTABBOTT LABORATORIES | 5,822 | $598K |
| AMGNAMGEN INC | 1,608 | $566K |
| ELVElevance Health Inc. | 1,405 | $411K |
| CORCencora Inc. | 1,168 | $367K |
| BMYBRISTOL MYERS SQUIBB CO | 3,988 | $242K |
| PFEPFIZER INC | 8,019 | $225K |
| HOWLWerewolf Therapeutics, Inc. | 14,925 | $12K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.